Retatrutide Vs Ozempic: Next-generation Jab Doubles Weight Loss In Trial

News18 - Oct 31, 2026

In the first head-to-head Phase 3 trial, Eli Lilly's “retatrutide” cut weight by up to 21% compared with about 9% on Ozempic

Read full article
MORE NEWS
About Us

Recent Discovery will take you to the captivating developments in science, technology, and the universe around us. We deliver to you the latest news, theories, and developments in the world of science.

Copyright © 2015 - 2026 Recent Discovery. All Rights Reserved.